Devers Shannon L. 4

What Happened

• Shannon L. Devers, Executive Vice President and Chief Human Resources Officer of Ionis Pharmaceuticals (IONS), sold 3,977 shares on January 22, 2026.
• The reported weighted-average price was $81.34 per share (range $81.33–$81.37), for gross proceeds of approximately $323,490. This was a sale (not a purchase).

Key Details

• Transaction date: 2026-01-22; Form 4 filed: 2026-01-23 (filed within the normal reporting window).
• Price: weighted average $81.34; reported sale prices ranged from $81.33 to $81.37.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: (1) The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Devers on September 3, 2024. (2) The reported price is a weighted average; the filer will provide a breakdown of the number of shares sold at each price upon request.
• Transaction type: open-market sale under a pre-arranged 10b5-1 plan.

Context

• Sales executed under Rule 10b5-1 plans are typically pre-arranged and do not, by themselves, indicate a change in the insider’s view of the company. This filing is informational and factual; no inference about company prospects should be drawn solely from this routine, pre-planned sale.